Holen Sie sich die Stockscreener-App
1.96
2.08%
0.04
Handel nachbörslich:
1.94
-0.02
-1.02%
Schlusskurs vom Vortag:
$1.92
Offen:
$1.95
24-Stunden-Volumen:
579.60K
Relative Volume:
0.70
Marktkapitalisierung:
$278.30M
Einnahmen:
$893.00K
Nettoeinkommen (Verlust:
$-151.61M
KGV:
-3.8043
EPS:
-0.5152
Netto-Cashflow:
$-135.31M
1W Leistung:
+7.69%
1M Leistung:
+8.29%
6M Leistung:
-30.25%
1J Leistung:
+184.06%
1-Tages-Spanne:
$1.87
$1.99
1-Wochen-Bereich:
$1.82
$1.99
52-Wochen-Spanne:
$0.54
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Compare PROK vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
1.96 | 272.62M | 893.00K | -151.61M | -135.31M | -0.5152 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
3 Promising Penny Stocks With Market Caps Up To $600M - simplywall.st
ProKidney (PROK) to Release Quarterly Earnings on Monday - MarketBeat
ProKidney approaches pivotal research, funding crossroads for drug therapy - Winston-Salem Journal
ProKidney Names Greg Madison as Chief Commercial Officer - HarianBasis.co
ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel - Insider Monkey
[SCHEDULE 13D/A] PROKIDNEY CORP. Amended Major Shareholder Report - Stock Titan
Control Empresarial converts 63.1M PROK (NASDAQ: PROK) Paired Interests into Class A shares - Stock Titan
Culleton - Winston-Salem Journal
9 Best Biotech Penny Stocks to Buy in 2026 - Insider Monkey
MSN Money - MSN
ProKidney spikes after mid-stage trial data for lead asset - MSN
ProKidney's top executive gains nearly threefold hike in 2025 compensation - Winston-Salem Journal
ProKidney (PROK) Stock Live Trade (On the Radar) 2026-04-20Late Breakout - Cổng thông tin điện tử tỉnh Lào Cai
ProKidney (NASDAQ:PROK) Upgraded to Sell at Wall Street Zen - MarketBeat
ProKidney (NASDAQ:PROK) Stock Price Up 9%Should You Buy? - MarketBeat
Executive pay, governance on agenda at ProKidney (NASDAQ: PROK) vote - Stock Titan
ProKidney Corp. (NASDAQ:PROK) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ProKidney (PROK) Stock: Trend Strength (Buying Pressure) 2026-04-15AI Powered Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
ProKidney (NASDAQ:PROK) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Bull Run: Can ProKidney Corp continue delivering strong returns2026 Key Highlights & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Winners Losers: Is ProKidney Corp impacted by rising rates2026 Market Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
High stakes: ProKidney pushes toward commercialization as cash dwindles, opportunity awaits - The Business Journals
Is ProKidney (PROK) Stock suitable for dividend investors | Price at $1.88, Up 1.35%Fundamentals - Cổng thông tin điện tử tỉnh Lào Cai
Analysis Recap: Will ProKidney Corp benefit from government policyQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Can ProKidney (PROK) Stock Reach New Highs | Price at $1.81, Down 4.74%Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
April 2026 Penny Stock Highlights - Sahm
Hennion & Walsh Asset Management Inc. Has $3.37 Million Holdings in ProKidney Corp. $PROK - MarketBeat
PROK Stock Analysis: ProKidney Corp falls 2.23% to $1.75, testing key biotech support - Cổng thông tin điện tử tỉnh Tây Ninh
Analysis Recap: What is the long term forecast for ProKidney Corp stockTrade Performance Summary & Low Drawdown Trading Strategies - baoquankhu1.vn
What Makes ProKidney Corp. (PROK) So Attractive - Yahoo Finance
Sell Signal: Will ProKidney Corp benefit from geopolitical trendsTrade Risk Summary & Real-Time Market Trend Scan - baoquankhu1.vn
Revenue Check: Does ProKidney Corp outperform in volatile markets2026 Drop Watch & Consistent Profit Trading Strategies - baoquankhu1.vn
ProKidney (NASDAQ:PROK) Shares Up 5.9%Here's Why - MarketBeat
5 Best Penny Stocks That Could Triple Your Money - Insider Monkey
Investment Report: What are the future prospects of ProKidney Corp2026 Earnings Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
ProKidney (MEX:PROK) PB Ratio : (As of Mar. 27, 2026) - GuruFocus
ProKidney hires chief commercial officer as key clinical test results near - Winston-Salem Journal
ProKidney names Greg Madison as chief commercial officer By Investing.com - Investing.com Australia
ProKidney appoints Greg Madison as chief commercial officer - TipRanks
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer - Bitget
ProKidney names Greg Madison as chief commercial officer - Investing.com
ProKidney expands senior leadership team with appointment of Greg Madison as chief commercial officer - marketscreener.com
ProKidney hires ex-Shield CEO Greg Madison for rilparencel launch prep - Stock Titan
Prokidney Expands Senior Leadership Team With Appointment Of Greg Madison As Chief Commercial Officer - TradingView
ProKidney (NASDAQ:PROK) Trading Down 7.6%Here's What Happened - MarketBeat
Q2 Earnings Forecast for ProKidney Issued By HC Wainwright - MarketBeat
ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Insider Sell: Does ProKidney Corp offer margin of safety2026 Outlook & Capital Efficiency Focused Ideas - baoquankhu1.vn
ProKidney A: Fundamental Analysis and Financial Ratings | PROK | KYG7S53R1049 - marketscreener.com
Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability - The Globe and Mail
ProKidney (NASDAQ:PROK) Cut to Sell at Wall Street Zen - MarketBeat
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):